The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paradela, A.
Right arrow Articles by López de Castro, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paradela, A.
Right arrow Articles by López de Castro, J. A.
The Journal of Immunology, 1998, 161: 5481-5490.
Copyright © 1998 by The American Association of Immunologists

The Same Natural Ligand Is Involved in Allorecognition of Multiple HLA-B27 Subtypes by a Single T Cell Clone: Role of Peptide and the MHC Molecule in Alloreactivity1

Alberto Paradela2,*, Marina García-Peydró2,*, Jesús Vázquez*, Didier Rognan{dagger} and José A. López de Castro3,*

* Centro de Biología Molecular Severo Ochoa (C.S.I.C.-U.A.M.), Universidad Autónoma de Madrid, Facultad de Ciencias, Madrid, Spain; and {dagger} Department of Pharmacy, ETH, Zürich, Switzerland

The human alloreactive CTL clone 27S69, raised against B*2705, cross-reacts with B*2702 and B*2703, but not with B*2701, B*2704, B*2706, or B*2710. Its natural epitope was identified by electrospray/ion trap mass spectrometry, as the proteasome-derived RRFFPYYV octamer. This is the first HLA-B27 ligand shown to be immunogenic in alloreactivity. The RRFFPYYVY nonamer, also found in the B*2705-bound peptide pool, was recognized much less efficiently, demonstrating that an alloreactive CTL distinguishes between very similar natural ligands. Molecular modeling suggested that this was due to the different conformation of each peptide in complex with B*2705. B*2702- and B*2703-RMA-S cells were lysed by CTL 27S69 when sensitized with the octamer, demonstrating that cross-reaction with these subtypes is through recognition of the same peptide as in B*2705. B*2704-, B*2706-, and B*2710-RMA-S cells were not sensitized for lysis, in spite of efficient binding of the octamer, indicating that polymorphism in these subtypes directly impairs allorecognition. B*2701-RMA-S and -C1R cells were sensitized for lysis by the octamer, suggesting lack of the endogenous peptide epitope on this subtype. Absence of the octamer in the B*2701-bound peptide pool further suggested that B*2701 polymorphism impairs the generation of this peptide.




This article has been cited by other articles:


Home page
Mol. Cell. ProteomicsHome page
J. J. Cragnolini and J. A. L. de Castro
Identification of Endogenously Presented Peptides from Chlamydia trachomatis with High Homology to Human Proteins and to a Natural Self-ligand of HLA-B27
Mol. Cell. Proteomics, January 1, 2008; 7(1): 170 - 180.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
M. Marcilla, J. J. Cragnolini, and J. A. Lopez de Castro
Proteasome-independent HLA-B27 Ligands Arise Mainly from Small Basic Proteins
Mol. Cell. Proteomics, May 1, 2007; 6(5): 923 - 938.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Merino, V. Montserrat, A. Paradela, and J. A.L. de Castro
Two HLA-B14 Subtypes (B*1402 and B*1403) Differentially Associated with Ankylosing Spondylitis Differ Substantially in Peptide Specificity but Have Limited Peptide and T-cell Epitope Sharing with HLA-B27
J. Biol. Chem., October 28, 2005; 280(43): 35868 - 35880.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. M. E. Whitelegg, L. E. M. Oosten, S. Jordan, M. Kester, A. G. S. van Halteren, J. A. Madrigal, E. Goulmy, and L. D. Barber
Investigation of Peptide Involvement in T Cell Allorecognition Using Recombinant HLA Class I Multimers
J. Immunol., August 1, 2005; 175(3): 1706 - 1714.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Sesma, B. Galocha, M. Vazquez, A. W. Purcell, M. Marcilla, J. McCluskey, and J. A. L. de Castro
Qualitative and Quantitative Differences in Peptides Bound to HLA-B27 in the Presence of Mouse versus Human Tapasin Define a Role for Tapasin as a Size-Dependent Peptide Editor
J. Immunol., June 15, 2005; 174(12): 7833 - 7844.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
A. W. Purcell and J. J. Gorman
Immunoproteomics: Mass Spectrometry-based Methods to Study the Targets of the Immune Response
Mol. Cell. Proteomics, March 1, 2004; 3(3): 193 - 208.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Sesma, I. Alvarez, M. Marcilla, A. Paradela, and J. A. L. de Castro
Species-specific Differences in Proteasomal Processing and Tapasin-mediated Loading Influence Peptide Presentation by HLA-B27 in Murine Cells
J. Biol. Chem., November 21, 2003; 278(47): 46461 - 46472.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Montserrat, M. Marti, and J. A. L. de Castro
Allospecific T Cell Epitope Sharing Reveals Extensive Conservation of the Antigenic Features of Peptide Ligands Among HLA-B27 Subtypes Differentially Associated with Spondyloarthritis
J. Immunol., June 1, 2003; 170(11): 5778 - 5785.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ramos, I. Alvarez, L. Sesma, A. Logean, D. Rognan, and J. A. Lopez de Castro
Molecular Mimicry of an HLA-B27-derived Ligand of Arthritis-linked Subtypes with Chlamydial Proteins
J. Biol. Chem., September 27, 2002; 277(40): 37573 - 37581.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ramos, A. Paradela, M. Vazquez, A. Marina, J. Vazquez, and J. A. Lopez de Castro
Differential Association of HLA-B*2705 and B*2709 to Ankylosing Spondylitis Correlates with Limited Peptide Subsets but Not with Altered Cell Surface Stability
J. Biol. Chem., August 2, 2002; 277(32): 28749 - 28756.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Sesma, V. Montserrat, J. R. Lamas, A. Marina, J. Vazquez, and J. A. L. de Castro
The Peptide Repertoires of HLA-B27 Subtypes Differentially Associated to Spondyloarthropathy (B*2704 and B*2706) Differ by Specific Changes at Three Anchor Positions
J. Biol. Chem., May 3, 2002; 277(19): 16744 - 16749.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. W. Purcell, J. J. Gorman, M. Garcia-Peydro, A. Paradela, S. R. Burrows, G. H. Talbo, N. Laham, C. A. Peh, E. C. Reynolds, J. A. Lopez de Castro, et al.
Quantitative and Qualitative Influences of Tapasin on the Class I Peptide Repertoire
J. Immunol., January 15, 2001; 166(2): 1016 - 1027.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Garcia-Peydro, A. Paradela, J. P. Albar, and J. A. L. d. Castro
Antagonism of Direct Alloreactivity of an HLA-B27-Specific CTL Clone by Altered Peptide Ligands of Its Natural Epitope
J. Immunol., November 15, 2000; 165(10): 5680 - 5685.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
N. Zavazava and D. Kabelitz
Alloreactivity and apoptosis in graft rejection and transplantation tolerance
J. Leukoc. Biol., August 1, 2000; 68(2): 167 - 174.
[Abstract] [Full Text]


Home page
J. Exp. Med.Home page
J. Yague, I. Alvarez, D. Rognan, M. Ramos, J. Vazquez, and J. A. L. de Castro
An N-acetylated Natural Ligand of Human Histocompatibility Leukocyte Antigen (HLA)-B39: Classical Major Histocompatibility Complex Class I Proteins Bind Peptides with a Blocked NH2 Terminus In Vivo
J. Exp. Med., June 12, 2000; 191(12): 2083 - 2092.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Paradela, I. Alvarez, M. Garcia-Peydro, L. Sesma, M. Ramos, J. Vazquez, and J. A. Lopez de Castro
Limited Diversity of Peptides Related to an Alloreactive T Cell Epitope in the HLA-B27-Bound Peptide Repertoire Results from Restrictions at Multiple Steps Along the Processing-Loading Pathway
J. Immunol., January 1, 2000; 164(1): 329 - 337.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Garcia-Peydro, A. Paradela, J. R. Lamas, and J. A. Lopez de Castro
Peptide Presentation to an Alloreactive CTL Clone Is Modulated Through Multiple Mechanisms Involving Polymorphic and Conserved Residues in HLA-B27
J. Immunol., December 1, 1999; 163(11): 6060 - 6064.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Garcia-Peydro, M. Marti, and J. A. Lopez de Castro
High T Cell Epitope Sharing Between Two HLA-B27 Subtypes (B*2705 and B*2709) Differentially Associated to Ankylosing Spondylitis
J. Immunol., August 15, 1999; 163(4): 2299 - 2305.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. R. Prilliman, K. W. Jackson, M. Lindsey, J. Wang, D. Crawford, and W. H. Hildebrand
HLA-B15 Peptide Ligands Are Preferentially Anchored at Their C Termini
J. Immunol., June 15, 1999; 162(12): 7277 - 7284.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Reinelt, M. Marti, S. Dedier, T. Reitinger, G. Folkers, J. A. L. de Castro, and D. Rognan
beta -Amino Acid Scan of a Class I Major Histocompatibility Complex-restricted Alloreactive T-cell Epitope
J. Biol. Chem., June 29, 2001; 276(27): 24525 - 24530.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Alvarez, L. Sesma, M. Marcilla, M. Ramos, M. Marti, E. Camafeita, and J. A. L. de Castro
Identification of Novel HLA-B27 Ligands Derived from Polymorphic Regions of Its Own or Other Class I Molecules Based on Direct Generation by 20 S Proteasome
J. Biol. Chem., August 24, 2001; 276(35): 32729 - 32737.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Alvarez, M. Marti, J. Vazquez, E. Camafeita, S. Ogueta, and J. A. Lopez de Castro
The Cys-67 Residue of HLA-B27 Influences Cell Surface Stability, Peptide Specificity, and T-cell Antigen Presentation
J. Biol. Chem., December 21, 2001; 276(52): 48740 - 48747.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.